Freestone Capital Holdings, LLC Abiomed Inc Transaction History

Freestone Capital Holdings, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$285.92 - $355.13 $243,032 - $301,860	-850 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$251.88 - $324.2 $62,970 - $81,050	-250 Reduced 22.73%	850 $276 Million
Q3 2020 Nov 06, 2020	SELL	$255.22 - $317.0 $63,805 - $79,250	-250 Reduced 18.52%	1,100 $304,000
Q2 2020 Aug 04, 2020	SELL	$141.4 - $257.09 $107,605 - $195,645	-761 Reduced 36.05%	1,350 $326,000
Q1 2020 May 12, 2020	BUY	$130.51 - $196.01 $275,506 - $413,777	2,111 New	2,111 $306,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Freestone Capital Holdings, LLC with notifications on news.